NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,199 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,199 Papers indexed
1,440 Papers AI scored
40,199 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-07 10:15 AM
1 Social Determinants of Sleep Health in Survivors of Childhood Cancer: A Systematic Review. Journal of sleep research — Nov 07, 2026 2 Primitive neuroectodermal tumour of the left posterior mandible. BMJ case reports — Nov 07, 2026 3 Adrenal ganglioneuroma in an adolescent presenting as an incidentaloma: Imaging-pathology correlation and diagnostic challenges: A case report. Medicine — Nov 07, 2026 4 Synchronous hepatocellular carcinoma and nasopharyngeal carcinoma in a patient with chronic hepatitis B: A case report and literature review. Medicine — Nov 07, 2026 5 Prenatal Trio Exome Sequencing in Low-Risk Pregnancies: Diagnostic Yield and Clinical Implications. Clinical genetics — Nov 07, 2026 6 Defining and validating an HPV vaccination motivation score in Kenya and Malawi: A tool for use in low- and middle-income countries. Vaccine — Nov 07, 2026 7 Drawing the Sacred: Visualizing Where Hope Lives in Hispanic Adolescent and Young Adult Cancer Survivorship. Journal of adolescent and young adult oncology — Nov 07, 2026 8 Social Isolation in Japanese Adolescents and Young Adults with Hematologic Malignancies: A Focus on Peer Relationships and Occupational Therapy Implications. Journal of adolescent and young adult oncology — Nov 07, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40199 results
C
Malignant pertussis in a young infant.
PMID 42710958 Published: 2026-09-08 Ingested: 2026-09-10 09:15 AM BMJ case reports
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Adnexal torsion due to teratoma in a young adolescent.
PMID 42708994 Published: 2026-08-11 Ingested: 2026-09-10 09:15 AM Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.
PMID 42704334 Published: 2026-01-01 Ingested: 2026-09-09 09:15 AM Journal of the Association of Genetic Technologists
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Behind the Curtain: A Pediatric Dermoid Tumor Masquerading as Craniopharyngioma.
PMID 42703536 Published: 2026-08-07 Ingested: 2026-09-09 09:15 AM Cureus
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
A screening-threshold-oriented framework reveals threshold-adjacent redistribution of global colorectal cancer burden: an analysis of GBD 2023.
PMID 42700379 Published: 2026-09-05 Ingested: 2026-09-08 09:15 AM Annals of medicine
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
The Case of Negative Low Density Lipoprotein Cholesterol.
PMID 42699499 Published: 2026-07-07 Ingested: 2026-09-08 09:15 AM EJIFCC
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Plexiform Fibrohistiocytic Tumor: An Updated Review.
PMID 42665406 Published: 2026-01-01 Ingested: 2026-08-30 09:15 AM In vivo (Athens, Greece)
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
The Journey with paediatric cancer: reflections on its impact on patients and their families.
PMID 42662956 Published: 2026-04-27 Ingested: 2026-08-30 09:15 AM The Pan African medical journal
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Proposal of an Algorithm for the Clinical and Molecular Diagnosis of RASopathies Based on HPO Nomenclature.
PMID 42653352 Published: 2026-08-17 Ingested: 2026-08-29 09:15 AM International journal of molecular sciences
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Beyond Oligodendroglioma: An Integrated Diagnostic Approach to CNS Tumors with Oligodendroglioma-like Morphology, with a Focus on Morphological Pitfalls, Immunoprofiles, and Molecular Signatures.
PMID 42653168 Published: 2026-08-11 Ingested: 2026-08-29 09:15 AM International journal of molecular sciences
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Bibliometric Analysis of Whole-Body MRI from 2015 to 2025 Across Clinical Applications, Quantitative Imaging, and Artificial Intelligence.
PMID 42645965 Published: 2026-08-08 Ingested: 2026-08-28 09:15 AM Journal of imaging
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
The economic costs of unpaid cancer caregiving: A qualitative study.
PMID 42629978 Published: 2026-08-21 Ingested: 2026-08-24 09:15 AM Palliative medicine
AI -
Standard 56.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

Previous
Page 2491 of 3350
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic